top of page


Hormonal therapy is a type of cancer treatment that involves the use of drugs to block or decrease the production of hormones in the body. Hormonal therapy is used primarily for the treatment of cancers that are hormone-sensitive, such as breast cancer and prostate cancer.

The goal of hormonal therapy is to reduce the levels of hormones in the body that are promoting the growth of cancer cells. This is achieved by either blocking the production of hormones or by preventing hormones from binding to their receptors.

In breast cancer, hormonal therapy is often used in combination with other treatments such as surgery, radiation therapy, and chemotherapy. In prostate cancer, hormonal therapy is often used as the initial treatment,  and it is also used in combination with radiation therapy or surgery. 

Screenshot 2023-03-17 at 9.41.34 AM.png

Apaluside (Apalutamide) is one of the best medications that is used to treat prostate cancer. It is an androgen receptor inhibitor. Apalutamide works by blocking the action of androgens (male hormones) on prostate cancer cells, which can slow the growth and spread of cancer. Know more.

Screenshot 2023-03-17 at 2.24.10 PM.png

Degarelix is used for the treatment of advanced prostate cancer. It is a type of gonadotropin-releasing hormone (GnRH) receptor antagonist, which works by blocking the action of GnRH in the body. GnRH is a hormone that stimulates the production of testosterone in the testicles, and testosterone is known to promote the growth and spread of prostate cancer. Know more.

Screenshot 2023-03-17 at 3.16.55 PM.png

Palbociclib is a novel cyclin-dependent kinase (CDK) inhibitor that works by blocking the activity of CDK4 and CDK6, two enzymes that play a key role in cell division and proliferation. By inhibiting CDK4/6 activity, palbociclib can slow down or stop the growth of cancer cells, potentially leading to remission or extended survival. Know more.

Screenshot 2023-03-17 at 2.31.41 PM.png

Fulvestrant is a Hormonal medication used to treat hormone receptor-positive metastatic breast cancer. It can be used as Mono-therapy and Also can be given in combination with Palbociclib. Hormone receptor-positive breast cancer is characterized by the presence of estrogen and/or progesterone receptors on the surface of cancer cells, which allow the cancer cells to grow and multiply in response to these hormones. Know more.

bottom of page